Impact of ADRB2 gene rs1042713 and rs1042714 polymorphisms on COPD
- VernacularTitle:ADRB2 генийн rs1042713 болон rs1042714 полиморфизм нь уушгины архаг бөглөрөлтөт өвчинд нөлөөлөх нь
- Author:
Chimedlkhamsuren G
1
;
Jambaldorj J
;
Odonchimeg P
;
Ichinnorov D
;
Sarantuya J
Author Information
1. Mongolian National University of Medical Science
- Publication Type:Journal Article
- Keywords:
Beta 2 Adrenergic Receptors;
Chronic Obstructive Pulmonary Disease;
Single Nucleotide Polymorphism;
Tumor Necrosis Factor-alpha
- From:Mongolian Medical Sciences
2016;175(1):17-20
- CountryMongolia
- Language:Mongolian
-
Abstract:
IntroductionMany factors can contribute to the occurrence of COPD. Recent studies have pointed to the notion thatpolymorphism of candidate genes may also play a signifi cant role in COPD pathogenesis.GoalTo investigate the association of polymorphisms in ADRB2 and TNF-α genes with COPD.Materials and MethodsWe genotyped three SNPs included rs1042713 and rs1042714 in ADRB2, rs1800629 in TNF-α gene,using PCR-RFLP method.ResultsThere is no statistically signifi cant difference was observed for TNF-α rs1800629 between case andcontrol groups. Genotype frequency of the homozygote Gly16 (rs1042713) was more frequent in COPDpatients than controls (OR=3.25; 95%CI, 1.58–6.66, p=0.0037). Also, haplotype frequency of Gly/Gly16+Gln/Glu27 was signifi cant difference among cases and controls (OR=5.03; 95%CI, 1.8–14.2,p<0.01).Conclusion:Overall, ADRB2 rs1042713 and rs1042714 polymorphisms are associated with increased susceptibilityto the development of COPD. Further studies in large groups of patients with COPD are needed toaddress other genetic risk factors.
